← All peptides

Pinealon

Short peptide bioregulator (Ala-Glu-Asp-Gly) studied for cognitive aging and pineal function.

Route
SUBQ
Typical dose range
100 mcg to 200 mcg
Frequency
daily
Half-life
2 hours
Cycle on / off (days)
10 / 90
Evidence grade
C

What Pinealon is

Pinealon is short peptide bioregulator (ala-glu-asp-gly) studied for cognitive aging and pineal function. It sits within neuropeptide research (attention, memory, stress resilience). Pepture keeps Pinealon in the library as a tracking target only, the app records what you enter but makes no recommendation about whether the compound is appropriate for you. That decision belongs with a licensed clinician.

Published pharmacokinetic data places the half-life of Pinealon at roughly 2 hours, and doses recorded in the community cluster around the 100 mcg to 200 mcg range. Individual protocols vary widely. Jurisdictional status (FDA-approved, prescription, or research only) depends on the specific formulation and country.

How people track Pinealon

In Pepture, Pinealon is typically logged alongside focus and mood ratings, sleep depth, work-session output, so cycle impact can be reviewed at the end of a block rather than by memory. The app captures dose, site, reconstitution ratio, cycle day, and any subjective rating you choose to add.

If you are considering Pinealon but have not started, or if you have started and want a second opinion, speak with a licensed clinician before changing any dose or cycle pattern.

Reconstitution math

Open the pre-filled Pinealon reconstitution calculator to compute syringe units per dose.

Reported Side Effects of Pinealon

Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.

  • Transient anxiety, restlessness, or headache PubMed
  • Dry mouth and nasal dryness with intranasal forms PubMed
  • Sleep disturbance if dosed late in the day PubMed
  • Mood changes reported in a subset of users PubMed

Compare Pinealon

How Pinealon stacks up against the peers most users consider.